Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-2.39%
↑ 97% above average
Average (22q)
-69.55%
Historical baseline
Range
High:346.19%
Low:-1633.95%
Volatility
-2847.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -2.39% |
| Q2 2025 | -148.45% |
| Q1 2025 | -1633.95% |
| Q4 2024 | 108.06% |
| Q3 2024 | -125.50% |
| Q2 2024 | 134.21% |
| Q1 2024 | 346.19% |
| Q4 2023 | -126.91% |
| Q3 2023 | 236.77% |
| Q2 2023 | -288.49% |
| Q1 2023 | 72.90% |
| Q4 2022 | 2.02% |
| Q3 2022 | -8.45% |
| Q2 2022 | -6.96% |
| Q1 2022 | -17.48% |
| Q4 2021 | -27.84% |
| Q3 2021 | -45.74% |
| Q2 2021 | -18.15% |
| Q1 2021 | 3.38% |
| Q4 2020 | -24.08% |
| Q3 2020 | -28.73% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |